Differential Inhibition by Nimesulide of the Early and Late Phases of Intravenous- and Intracerebroventricular-LPS-Induced Fever in Guinea Pigs
The DOI matches its Crossref record; 54 of the 54 references it cites were found in a registry or an index.
Abstract
Objectives: The findings that inducible cyclooxygenase (COX)-2, but not constitutive COX-1, is upregulated in the brain of conscious rats ∼1.5 h after intraperitoneal pyrogen administration, that the systemic administration of COX-2 inhibitors abolishes fever, and that COX-2-deficient mice do not develop fever in response to intraperitoneal lipopolysaccharide (LPS) have strongly implicated COX-2 in the mediation of the febrile response. However, the biosynthesis of COX-2 is significantly slower than the onset of the fever produced by intravenously injected LPS. It consequently seems improbable that inducible COX-2 could play a role in the initiation of this febrile response, but a role for COX-1 has not yet been categorically ruled out; or, alternatively, a constitutive isoform of COX-2 could have such a role. We have studied, therefore, the effects of the non-selective COX inhibitor indomethacin, the COX-1-selective inhibitor SC-560, and the COX-2-selective inhibitor nimesulide on the characteristically biphasic fever induced by intravenous LPS in conscious guinea pigs; it has an onset latency of ∼10 min. Methods: We injected the inhibitors 30 min before LPS, in various combinations of doses and routes; their respective vehicles were the control solutions. Core temperatures (T c) were monitored continuously, and plasma and brain PGE 2 levels were measured before and at 2-hour intervals after LPS administration. Results: Intraperitoneal indomethacin at 10 mg kg–1 attenuated both phases of intravenous LPS (2 µg kg–1) fever, but the first more so than the second; at 50 mg kg–1, it inhibited the febrile response completely. Intraperitoneal SC-560 (5 mg kg–1) did not affect the febrile response to intravenous LPS (2 µg kg–1). Intraperitoneal nimesulide (0.3, 1.0, and 3.0 mg kg–1) dose dependently attenuated intravenous LPS (0.1 and 2 µg kg–1) fever; the second phase of the biphasic T c rise was affected significantly more than the first. Intraperitoneal nimesulide also prevented the associated rises in plasma and brain PGE 2 levels. Intracerebroventricular LPS (150 ng kg–1) evoked a monophasic fever with a long onset latency (∼30 min); it was accompanied by a rise in brain PGE 2 only, implying that the febrigenic PGE 2 was generated directly in the brain. This response, however, was completely abolished by intraperitoneal nimesulide (3 mg kg–1), indicating that nimesulide crosses the blood-brain barrier. Intracerebroventricular nimesulide at 0.3 mg kg–1 prevented the rise in plasma PGE 2 after intravenous LPS (2 µg kg–1) and again attenuated the second febrile peak significantly more than the first. Conclusions: COX-1 is not involved in intravenous LPS fever production, and COX-2 appears to play a greater role in the late than in the early phase of intravenous LPS fever in guinea pigs. The involvement of a constitutive COX-2 is inferred in the early phase.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“It is therefore not surprising that SC560, a selective COX-1 inhibitor, does not exhibit antipyretic actions [125].”
From Paracetamol (acetaminophen): A familiar drug with an unexplained mechanism of action (2021) · cites this paper as [125]
In the citing paper
“Blockade of brain PGE 2 synthesis by NSAIDs has been associated with the antipyretic action of these drugs, which has been suggested to be due to inhibition of inducible COX-2 produced by hypothalamic vascular endothelial cells [124,125].”
From Paracetamol (acetaminophen): A familiar drug with an unexplained mechanism of action (2021) · cites this paper as [125]
Citations
Cites
Yamagata, K., Andreasson, K. I., Kaufmann, W. E., Barnes, C. A., & Worley, P. F. (1993) · Neuron · doi:10.1016/0896-6273(93)90192-t · Cited by 1,226
Fever: Role of Pyrogens and Cryogens
Kluger, M. J. (1991) · Physiological Reviews · doi:10.1152/physrev.1991.71.1.93 · Cited by 1,215
Herschman, H. R. (1996) · Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism · doi:10.1016/0005-2760(95)00194-8 · Cited by 1,197
Pharmacological analysis of cyclooxygenase-1 in inflammation
Smith, C. J., Zhang, Y., Koboldt, C. M., Muhammad, J., Zweifel, B. S., Shaffer, A., Talley, J. J., Masferrer, J. L., Seibert, K., & Isakson, P. C. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.22.13313 · Cited by 807
Tanioka, T., Nakatani, Y., Semmyo, N., Murakami, M., & Kudo, I. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m003504200 · Cited by 708
Cyclooxygenase-2: Molecular Biology, Pharmacology, and Neurobiology
O'Banion, M. K. (1999) · Critical Reviews in Neurobiology · doi:10.1615/critrevneurobiol.v13.i1.30 · Cited by 404
Yamagata, K., Matsumura, K., Inoue, W., Shiraki, T., Suzuki, K., Yasuda, S., Sugiura, H., Cao, C., Watanabe, Y., & Kobayashi, S. (2001) · The Journal of Neuroscience · doi:10.1523/jneurosci.21-08-02669.2001 · Cited by 371
Mechanism of Action of Acetaminophen: Is There a Cyclooxygenase 3?
Botting, R. M. (2000) · Clinical Infectious Diseases · doi:10.1086/317520 · Cited by 350
Pathway across the blood–brain barrier
Ek, M., Engblom, D., Saha, S., Blomqvist, A., Jakobsson, P.-J., & Ericsson-Dahlstrand, A. (2001) · Nature · doi:10.1038/35068632 · Cited by 348
Murakami, M., Kambe, T., Shimbara, S., & Kudo, I. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.5.3103 · Cited by 348
Cited by
Chandrasekharan, N. V., Dai, H., Roos, K. L. T., Evanson, N. K., Tomsik, J., Elton, T. S., & Simmons, D. L. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.162468699 · Cited by 1,989
Maulik, P. K., & Darmstadt, G. L. (2007) · Pediatrics · doi:10.1542/peds.2007-0043b · Cited by 296
Konsman, J. P., Vigues, S., Mackerlova, L., Bristow, A., & Blomqvist, A. (2004) · Journal of Comparative Neurology · doi:10.1002/cne.20052 · Cited by 257
“…cells expressing IL-1R1s plays an important role after LPS administration is supported by the finding that the IL-1 receptor antagonist inhibits LPS-induced fever (Luheshi et al., 1996), a COX-2 dependent response (Cao et al., 1997; Steiner et al., 2001; Roth et al., 2002; Zhang et al., 2003).”
BackgroundProstaglandin E2 as a mediator of fever: synthesis and catabolism
Ivanov, A. (2004) · Frontiers in Bioscience · doi:10.2741/1383 · Cited by 242
“Differential regulation at three phases of lipopolysaccharide fever Studies with pharmacological inhibition of PG synthesis (10, 13, 14, 66) and experiments in PGE receptor knockout mice (5) strongly suggest that PGE2 is involved in all three febrile phases.”
BackgroundInfluentialParacetamol (acetaminophen): A familiar drug with an unexplained mechanism of action
Ayoub, S. S. (2021) · Temperature · doi:10.1080/23328940.2021.1886392 · Cited by 223
“Blockade of brain PGE2 synthesis by NSAIDs has been associated with the antipyretic action of these drugs, which has been suggested to be due to inhibition of inducible COX-2 produced by hypothalamic vascular endothelial cells [124,125].”
BackgroundCellular and Molecular Bases of the Initiation of Fever
Steiner, A. A., Ivanov, A. I., Serrats, J., Hosokawa, H., Phayre, A. N., Robbins, J. R., Roberts, J. L., Kobayashi, S., Matsumura, K., Sawchenko, P. E., et al. (2006) · PLoS Biology · doi:10.1371/journal.pbio.0040284 · Cited by 185
“(present study), the ability of drugs to cross the BBB, and consequently, their tendency to be distributed evenly between the peripheral compartment and the brain [32].”
BackgroundSelf-citationEndotoxic fever: New concepts of its regulation suggest new approaches to its management
Blatteis, C. M. (2006) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2005.10.013 · Cited by 172
Self-citationThe onset of fever: new insights into its mechanism
Blatteis, C. M. (2007) · Progress in brain research · doi:10.1016/s0079-6123(06)62001-3 · Cited by 179
“This raises the possibility that, as was conceived earlier in regard to the cytokines, the PGE2 that acts in the VMPO could enter it from the blood: being lipophilic, it could either cross the blood-brain barrier (BBB) or diffuse to this site through ‘‘leaky’’ ports in the barrier, e.g., the organum vasculosum laminae…”
BackgroundInfluentialSelf-citationFever and hypothermia in systemic inflammation
Garami, A., Steiner, A. A., & Romanovsky, A. A. (2018) · Handbook of clinical neurology · doi:10.1016/b978-0-444-64074-1.00034-3 · Cited by 171
Self-citationStroke in Rural Areas and Small Communities
Joubert, J., Prentice, L. F., Moulin, T., Liaw, S.-T., Joubert, L. B., Preux, P.-M., Ware, D., Medeiros de Bustos, E., & McLean, A. (2008) · Stroke · doi:10.1161/strokeaha.107.501643 · Cited by 131
Zhang, Y., Lu, J., Elmquist, J. K., & Saper, C. B. (2003) · Journal of Comparative Neurology · doi:10.1002/cne.10743 · Cited by 102
“In addition, Blatteis and colleagues (Li et al., 1999; Steiner et al., 2001) found that mice with deletion of the COX-1 gene, or guinea pigs treated with the COX-1 inhibitor SC-560, had normal fever responses to i.p. LPS.”
BackgroundResultInfluentialBotting, R. M. (2003) · Thrombosis Research · doi:10.1016/s0049-3848(03)00411-0 · Cited by 107
“Indomethacin prevented the biphasic LPS-induced fever in guinea pigs [16].”
BackgroundPremature mortality in active convulsive epilepsy in rural Kenya: Causes and associated factors
Ngugi, A. K., Bottomley, C., Fegan, G., Chengo, E., Odhiambo, R., Bauni, E., Neville, B. G. R., Kleinschmidt, I., Sander, J. W. A. S., & Newton, C. R. J. C. (2014) · Neurology · doi:10.1212/wnl.0000000000000123 · Cited by 80
Li, S., Goorha, S., Ballou, L. R., & Blatteis, C. M. (2003) · Brain Research · doi:10.1016/j.brainres.2003.08.033 · Cited by 68
Self-citationWalker, R. W. (2000) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.68.6.744 · Cited by 59
Cyclooxygenase-1 or -2—which one mediates lipopolysaccharide-induced hypothermia?
Steiner, A. A., Hunter, J. C., Phipps, S. M., Nucci, T. B., de Oliveira, D. L., Roberts, J., Scheck, A. C., Simmons, D. L., & Romanovsky, A. A. (2009) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.91026.2008 · Cited by 67
“Clinical fevers (5) and all phases of experimental, LPS-induced fever (13, 49, 81, 83, 90) are thought to be mediated by COX-2, the inducible isoform, and not by COX-1, the predominantly constitutive isoform.”
BackgroundSelf-citationMouihate, A., Clerget-Froidevaux, M.-S., Nakamura, K., Negishi, M., Wallace, J. L., & Pittman, Q. J. (2002) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00258.2002 · Cited by 58
“As COX-2 appears obligatory for an LPS fever to develop, it is likely that constitutive COX-2 may contribute to the early phase of fever (46).”
Feleder, C., Perlík, V., & Blatteis, C. M. (2004) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00486.2003 · Cited by 56
Self-citationPyrogenicity of CpG-DNA in mice: role of interleukin-6, cyclooxygenases, and nuclear factor-κB
Kozak, W., Wrotek, S., & Kozak, A. (2005) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00408.2005 · Cited by 50
Le, T. D., Shirai, Y., Okamoto, T., Tatsukawa, T., Nagao, S., Shimizu, T., & Ito, M. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0915020107 · Cited by 57
“Nimesulide at 1 mg/kg body weight is known to minimally interfere with PGE2 production in the brain, and at 3 mg/kg body weight, maximally for 2 h (33).”
BackgroundIvanov, A. I., Scheck, A. C., & Romanovsky, A. A. (2003) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00570.2002 · Cited by 50
Rainsford, K. D. (2005) · Birkhäuser Basel eBooks · doi:10.1007/3-7643-7410-1 · Cited by 64
Clinical features and prognosis of amyotrophic lateral sclerosis in Africa: the TROPALS study
Luna, J., Diagana, M., Aissa, L. A., Tazir, M., Pacha, L. A., Kacem, I., Gouider, R., Henning, F., Basse, A. M., Cisse, O., et al. (2018) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp-2018-318469 · Cited by 54
Expanding the febrigenic role of cyclooxygenase-2 to the previously overlooked responses
Steiner, A. A., Rudaya, A. Y., Robbins, J. R., Dragic, A. S., Langenbach, R., & Romanovsky, A. A. (2005) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00371.2005 · Cited by 42
Self-citationThe prevalence of essential tremor in rural northern Tanzania
Dotchin, C. L., & Walker, R. W. (2008) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.2007.134304 · Cited by 39
Rummel, C., Barth, S. W., Voss, T., Korte, S., Gerstberger, R., Hübschle, T., & Roth, J. (2005) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00104.2005 · Cited by 37
“This time point was chosen according to data from the literature on peripheral LPSinduced formation of PGE2 (36) and according to our own pilot measurements showing consistently elevated PGE2 concentrations in lavage fluid 2 h after LPS administration.”
MethodIndomethacin impairs LPS-induced behavioral fever in toads
Bícego, K. C., Steiner, A. A., Antunes‐Rodrigues, J., & Branco, L. G. S. (2002) · Journal of Applied Physiology · doi:10.1152/japplphysiol.00121.2002 · Cited by 34
Self-citationVoß, T., Barth, S. W., Rummel, C. D., Gerstberger, R., Hübschle, T., & Roth, J. (2007) · Cell and Tissue Research · doi:10.1007/s00441-007-0386-6 · Cited by 31
“The use of selective COX2 inhibitors (Cao et al. 1997; Steiner et al. 2001; Zhang et al. 2003; Fabricio et al. 2004) or of COX-2-deficient (“knockout”) mice (Li et al.”
BackgroundInfluentialGlucagon induces airway smooth muscle relaxation by nitric oxide and prostaglandin E2
Insuela, D. B. R., Daleprane, J. B., Coelho, L. P., Silva, A. R., Silva, P. M. R. E., Martins, M. A., & Carvalho, V. F. (2015) · Journal of Endocrinology · doi:10.1530/joe-14-0648 · Cited by 28
“2001) or SC-560 (5 mg/kg) (Steiner et al. 2001) 30 min before glucagon administration.”
MethodThe cytokine-prostaglandin cascade in fever production: fact or fancy?
Blatteis, C. M. (2004) · Journal of Thermal Biology · doi:10.1016/j.jtherbio.2004.08.008 · Cited by 31
Self-citationComparison between two cyclooxygenase inhibitors in an experimental dry eye model in albino rabbits
Elshazly, A. H. M., Elgohary, A. A., Elshazly, L. H. M., & El-Hossary, G. G. (2008) · Acta Pharmaceutica · doi:10.2478/v10007-008-0009-0 · Cited by 31
A systematic review of the worldwide prevalence of survivors of poliomyelitis reported in 31 studies
Jones, K., Balalla, S. K., Theadom, A., Jackman, G., & Feigin, V. L. (2017) · BMJ Open · doi:10.1136/bmjopen-2016-015470 · Cited by 23
Role of the brain heme oxygenase-carbon monoxide pathway in stress fever in rats
Steiner, A. A., Reste, G., & Branco, L. G. S. (2003) · Neuroscience Letters · doi:10.1016/s0304-3940(03)00197-6 · Cited by 23
Self-citationBotting, R. M. (2004) · Frontiers in bioscience · doi:10.2741/1303 · Cited by 27
Nigussie, K., Tesfaye, B., Lemma, A., & Kerebih, H. (2021) · BMJ Open · doi:10.1136/bmjopen-2020-043227 · Cited by 19
Soriano, R. N., & Branco, L. G. S. (2010) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2010.04.018 · Cited by 17
“This response is no longer observed after training (Steiner et al., 2001), supporting its psycho-emotional bases.”
BackgroundRowland, S. E., Clark, P., Gordon, R. J., Grey, A. K. M., Guay, J., Dufresne, L., Brideau, C., Côté, B., Ducharme, Y., Mancini, J. A., et al. (2007) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2007.01.008 · Cited by 16
TTF-1 Action on the Transcriptional Regulation of Cyclooxygenase-2 Gene in the Rat Brain
Yun, C. H., Kim, J. G., Park, B. S., Lee, H. M., Kim, D. H., Kim, E. O., Park, J., Park, J. W., Damante, G., Kim, Y. I., et al. (2011) · PLoS ONE · doi:10.1371/journal.pone.0028959 · Cited by 13
“Then, EP3 receptors mediate the pyretic action of PGE2; mutant mice lacking this receptor do not develop fever after administration of PGE2, IL-1 or LPS [5].”
BackgroundPossible sequence of pyrogenic afferent processing in the POA
Blatteis, C. M., Feleder, C., Perlík, V., & Li, S. (2004) · Journal of Thermal Biology · doi:10.1016/j.jtherbio.2004.08.010 · Cited by 15
Self-citationWerner, M. F. D. P., de Souza, G. E. P., & Zampronio, A. R. (2006) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2006.05.029 · Cited by 14
Phillippe, M., Diamond, A. K., Sweet, L. M., Oppenheimer, K. H., & Bradley, D. F. (2011) · Reproductive Sciences · doi:10.1177/1933719111404607 · Cited by 10
Anzai, M., & Nagao, S. (2014) · Neuroscience Research · doi:10.1016/j.neures.2014.04.002 · Cited by 10
Fever as a Host Defense Mechanism
Blatteis, C. M. (2010) · Neuroimmune biology · doi:10.1016/s1567-7443(10)70023-5 · Cited by 15
Self-citationMapulanga, M., Kgarosi, K., Maluleke, K., Hlongwa, M., & Dlungwane, T. P. (2024) · BMJ Open · doi:10.1136/bmjopen-2023-079738 · Cited by 11
Matsumura, S., Shibakusa, T., Fujikawa, T., Yamada, H., Matsumura, K., Inoue, K., & Fushiki, T. (2007) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00181.2007 · Cited by 9
“Nimesulide and NS398 possess high selectivity for COX-2, as shown by several studies (26, 32, 57, 59).”
BackgroundPharmacological properties of nimesulide
Rainsford, K. D., Bevilacqua, M. T., Dallegri, F., Gago, F., Ottonello, L. C., Sandrini, G., Tassorelli, C., & Tavares, I. G. (2005) · Birkhäuser Basel eBooks · doi:10.1007/3-7643-7410-1_4 · Cited by 8
The State of Play of Parkinson’s Disease in Africa: A Systematic Review and Point of ViewPreprint
Okunoye, O., Zewde, Y. Z., Azar, J., Ayele, B. A., Dindayal, S., Moustafa, A., Abdulkarim, M., Taiwo, F., Massi, D. G., Salama, M., et al. (2023) · medRxiv · doi:10.1101/2023.07.07.23292392 · Cited by 5
RESPECTIVELY, PGE2-INDEPENDENT AND PGE2-DEPENDENT HYPERTHERMIC RESPONSES IN GUINEA PIGS.
Feleder, C., Perlík, V., & Blatteis, C. M. (2004)
Self-citationKronik bel ve boyun ağrılı hastada temel analjezikler
Eroğlu, M., & Eyigör, S. (2017) · Türk Ortopedi ve Travmatoloji Birliği Derneği · doi:10.14292/totbid.dergisi.2017.20
Papel da ciclooxigenase-1 no choque endotóxico.
Brito, C. F. (2018) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/d.42.2018.tde-16022018-153419
Metadata
- Authors
- Steiner, A. A., Li, S., Llanos-Q., J., & Blatteis, C. M.
- Affiliations
- University of Tennessee Health Science Center (US)
- Venue
- Neuroimmunomodulation
- Publisher
- S. Karger AG
- Published
- 2001
- Volume
- 9
- Issue
- 5
- Pages
- 263-275
- ISSN
- 1021-7401 (ISSN-L)
- 1423-0216
- OpenAlex
- W1964949469
- Cited by
- 50
- References
- 54
- Citations by year
- 2024: 1 · 2023: 1 · 2021: 2 · 2018: 3 · 2017: 2 · 2015: 1 · 2014: 2
- FWCI
- 4.24
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.karger.com/Services/SiteLicenses (vor)
- www.karger.com/Services/SiteLicenses (tdm)
- Locations
- NeuroImmunoModulation (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institute of Neurological Disorders and Stroke (NS/AI38594)
- Topics
- Health Sciences › Medicine › Critical Care and Intensive Care Medicine › Thermal Regulation in Medicine
- Health Sciences › Medicine › Pharmacology (medical) › Inflammatory mediators and NSAID effects
- Health Sciences › Medicine › Physiology (medical) › Pain Mechanisms and Treatments
- Keywords
- nimesulide, lipopolysaccharide-induced fever, biphasic fever, cyclooxygenase-2, cyclooxygenase-1, indomethacin, SC-560, febrile response, prostaglandin E2, guinea pig
- MeSH terms
- Animals, Anti-Inflammatory Agents, Non-Steroidal, Blood-Brain Barrier, Brain, Dose-Response Relationship, Drug, Fever, Guinea Pigs, Indomethacin, Injections, Intraperitoneal, Injections, Intravenous, Injections, Intraventricular, Isoenzymes, Lipopolysaccharides, Male, Prostaglandin-Endoperoxide Synthases, Pyrazoles, Sulfonamides, Dinoprostone, Cyclooxygenase Inhibitors, Cyclooxygenase 1, Cyclooxygenase 2, Cyclooxygenase 2 Inhibitors
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.